U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 7

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr4:1808331
GRCh38:
Chr4:1806604
FGFR3G697C, G699C, G585C, R674L, G698CCarcinoma, Urinary bladder carcinomaLikely pathogenic
(May 13, 2016)
no assertion criteria provided
2.
GRCh37:
Chr4:1806089
GRCh38:
Chr4:1804362
FGFR3G370C, G372Cnot provided, Thanatophoric dysplasia type 1Pathogenic
(Dec 5, 2022)
criteria provided, multiple submitters, no conflicts
3.
GRCh37:
Chr4:1807889
GRCh38:
Chr4:1806162
FGFR3K650Q, K652Q, K651Q, K538Qnot provided, HypochondroplasiaPathogenic
(Jun 2, 2023)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr4:1806099
GRCh38:
Chr4:1804372
FGFR3Y373C, Y375Cnot provided, Thanatophoric dysplasia type 1Conflicting interpretations of pathogenicity
(Oct 24, 2022)
criteria provided, conflicting interpretations
5.
GRCh37:
Chr4:1803568
GRCh38:
Chr4:1801841
FGFR3S249CMalignant tumor of testis, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Epidermal nevus,
Muenke syndrome, Levy-Hollister syndrome, Achondroplasia,
Cervix cancer, Malignant tumor of urinary bladder, Hypochondroplasia,
Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Carcinoma of colonThanatophoric dysplasia type 1,
Thanatophoric dysplasia, type 2, Crouzon syndrome-acanthosis nigricans syndrome, Connective tissue disorder,
FGFR3-related condition, not provided, Malignant tumor of urinary bladder,
Cervix cancer, Thanatophoric dysplasia type 1, ...see more
Pathogenic
(Feb 23, 2023)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr4:1806092
GRCh38:
Chr4:1804365
FGFR3S371C, S373Cnot specified, not providedPathogenic
(May 10, 2022)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr11:534289
GRCh38:
Chr11:534289
HRAS, LRRC56G12CEpidermal nevus, Linear nevus sebaceous syndrome, Large congenital melanocytic nevus,
Costello syndrome, Malignant tumor of urinary bladder, Thyroid cancer, nonmedullary, 2,
not provided, Costello syndrome
Pathogenic
(Sep 21, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination